Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 68539-16-2
2. 2,3:4,6-di-o-isopropylidene-2-keto-l-gulonicacidmonohydrate
3. (1r,2s,6r,8s)-4,4,11,11-tetramethyl-3,5,7,10,12-pentaoxatricyclo[6.4.0.02,6]dodecane-6-carboxylic Acid;hydrate
4. (-)-2,3:4,6-di-o-isopropylidene-2-keto-l-gulonic Acid Monohydrate
5. Dikegulac Monohydrate
6. (3as,3br,7as,8ar)-2,2,5,5-tetramethyltetrahydro-3ah-[1,3]dioxolo[4',5':4,5]furo[3,2-d][1,3]dioxine-8a-carboxylic Acid Hydrate
7. Mfcd00150517
8. 2,3:4,6-di-o-isopropylidene-2-keto-l-gulonic Acid
9. Schembl2062735
10. Amy40592
11. Akos015892738
12. As-10325
13. Cs-0017944
14. F20377
15. W-203261
16. W-203523
17. (-)-2,3:4,6-di-o-isoproyplidene-2-keto-l-gulonic Acid Monohydrate
18. (-)-2,3:4,6-di-o-isopropylidene-2-keto-l-gulonic Acid Monohydrate, 98%
19. (−)-2,3:4,6-di-o-isopropylidene-2-keto-
20. 2,3:4,6-bis-o-(1-methylethylidene)-
21. A-l-xylo-2-hexulofuranosonic Acid Hydrate (1:1)
22. A-l-xylo-2-hexulofuranosonic Acid,2,3:4,6-bis-o-(1-methylethylidene)-, Hydrate (1:1)
23. (3ar,4as,8ar,8bs)-2,2,7,7-tetramethyl-4a,5,8a,8b-tetrahydro-[1,3]dioxolo[3,4]furo[1,3-d][1,3]dioxine-3a-carboxylic Acid;hydrate
| Molecular Weight | 292.28 g/mol |
|---|---|
| Molecular Formula | C12H20O8 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 8 |
| Rotatable Bond Count | 1 |
| Exact Mass | 292.11581759 g/mol |
| Monoisotopic Mass | 292.11581759 g/mol |
| Topological Polar Surface Area | 84.4 Ų |
| Heavy Atom Count | 20 |
| Formal Charge | 0 |
| Complexity | 418 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 4 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
Market Place
ABOUT THIS PAGE
82
PharmaCompass offers a list of Dikegulac monohydrate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Dikegulac monohydrate manufacturer or Dikegulac monohydrate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Dikegulac monohydrate manufacturer or Dikegulac monohydrate supplier.
PharmaCompass also assists you with knowing the Dikegulac monohydrate API Price utilized in the formulation of products. Dikegulac monohydrate API Price is not always fixed or binding as the Dikegulac monohydrate Price is obtained through a variety of data sources. The Dikegulac monohydrate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Dikegulac monohydrate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Dikegulac monohydrate, including repackagers and relabelers. The FDA regulates Dikegulac monohydrate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Dikegulac monohydrate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Dikegulac monohydrate supplier is an individual or a company that provides Dikegulac monohydrate active pharmaceutical ingredient (API) or Dikegulac monohydrate finished formulations upon request. The Dikegulac monohydrate suppliers may include Dikegulac monohydrate API manufacturers, exporters, distributors and traders.
Dikegulac monohydrate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Dikegulac monohydrate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Dikegulac monohydrate GMP manufacturer or Dikegulac monohydrate GMP API supplier for your needs.
A Dikegulac monohydrate CoA (Certificate of Analysis) is a formal document that attests to Dikegulac monohydrate's compliance with Dikegulac monohydrate specifications and serves as a tool for batch-level quality control.
Dikegulac monohydrate CoA mostly includes findings from lab analyses of a specific batch. For each Dikegulac monohydrate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Dikegulac monohydrate may be tested according to a variety of international standards, such as European Pharmacopoeia (Dikegulac monohydrate EP), Dikegulac monohydrate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Dikegulac monohydrate USP).
